Current Readings: Single vs Bilateral Internal Mammary Artery in Coronary Artery Bypass Grafting

Julius I Ejiofor1, Tsuyoshi Kaneko1, Sary F Aranki1

  • 1Division of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Insights

Bilateral internal mammary artery (BIMA) grafting shows potential for better long-term survival, but risks like sternal infection and longer surgery times need consideration. Further data is needed to confirm its effectiveness.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Surgical Outcomes

Background:

  • Retrospective studies suggest bilateral internal mammary artery (BIMA) grafting improves long-term survival compared to single left internal mammary artery (LIMA) grafting.
  • The Arterial Revascularization Trial's interim results have not yet confirmed this survival advantage.
  • Widespread adoption of BIMA grafting faces challenges, including a higher risk of deep sternal wound infection.

Purpose of the Study:

  • To evaluate the effectiveness and risks associated with bilateral internal mammary artery (BIMA) grafting in coronary artery bypass surgery.
  • To compare long-term survival outcomes between BIMA and LIMA grafting.
  • To identify strategies for mitigating complications associated with BIMA grafting.

Main Methods:

  • Review of retrospective data and interim results from the Arterial Revascularization Trial.
  • Analysis of surgical techniques, including skeletonized harvesting and Y-graft configuration for BIMA.
  • Assessment of operative time, in-hospital costs, and sternal wound infection rates.

Main Results:

  • Retrospective data indicates superior long-term survival with BIMA grafting.
  • Interim results from the Arterial Revascularization Trial have not corroborated the survival benefit.
  • Skeletonized harvesting and Y-graft utilization may reduce infection risk and improve revascularization, respectively.
  • BIMA grafting is associated with increased operative time (approx. 25 minutes) and higher costs.

Conclusions:

  • The definitive long-term effectiveness of BIMA grafting remains uncertain pending final results of the Arterial Revascularization Trial.
  • Strategies to minimize sternal wound infection, such as skeletonized harvesting, are crucial for BIMA adoption.
  • Balancing the potential survival benefits against increased operative time, costs, and infection risks is essential.

Keywords:
BIMACABGLIMA

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
504
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
292
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
404
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
709
Arteries of Lower Limbs01:20

Arteries of Lower Limbs

The external iliac artery transitions out of the body cavity, entering the femoral region of the lower leg, and is renamed the femoral artery at the point where it traverses the body wall. This artery is responsible for the distribution of blood to the thigh's deep muscles and the skin's ventral and lateral regions, achieved through several minor branches and the lateral deep femoral artery, which also spawns a lateral circumflex artery. The knee area receives blood from the genicular...
4.8K